The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Immunofluorescence Assays-Global Market Insights and Sales Trends 2024

Immunofluorescence Assays-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1863608

No of Pages : 102

Synopsis
Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all disciplines of biology including medicine for diagnostics and research. Immunofluorescence assays are used to detect specific proteins in cells that may be in specimen, in culture, in tissues, on microbeads and microarrays, etc.
The global Immunofluorescence Assays market size is expected to reach US$ 2196.9 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Immunofluorescence Assays in various end use industries. The expanding demands from the Clinical Research and Laboratory Diagnostics, are propelling Immunofluorescence Assays market. Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Kits and Reagents segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immunofluorescence Assays market, driven by demand from China, the second largest economy with some signs of stabilising, the Immunofluorescence Assays market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunofluorescence Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunofluorescence Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunofluorescence Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunofluorescence Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunofluorescence Assays covered in this report include Thermo Fisher, Inova Diagnostics, Bio-Rad, Abcam, PerkinELmer, Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH and Sino Biological, etc.
The global Immunofluorescence Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Inova Diagnostics
Bio-Rad
Abcam
PerkinELmer
Merck Millipore
Cell Signaling Technology
MEDIPAN GMBH
Sino Biological
Danaher
Vector Laboratories
Global Immunofluorescence Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunofluorescence Assays market, Segment by Type:
Antibodies
Kits and Reagents
Labeling Dyes
Global Immunofluorescence Assays market, by Application
Clinical Research
Laboratory Diagnostics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunofluorescence Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Immunofluorescence Assays
1.1 Immunofluorescence Assays Market Overview
1.1.1 Immunofluorescence Assays Product Scope
1.1.2 Immunofluorescence Assays Market Status and Outlook
1.2 Global Immunofluorescence Assays Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immunofluorescence Assays Market Size by Region (2018-2029)
1.4 Global Immunofluorescence Assays Historic Market Size by Region (2018-2023)
1.5 Global Immunofluorescence Assays Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immunofluorescence Assays Market Size (2018-2029)
1.6.1 North America Immunofluorescence Assays Market Size (2018-2029)
1.6.2 Europe Immunofluorescence Assays Market Size (2018-2029)
1.6.3 Asia-Pacific Immunofluorescence Assays Market Size (2018-2029)
1.6.4 Latin America Immunofluorescence Assays Market Size (2018-2029)
1.6.5 Middle East & Africa Immunofluorescence Assays Market Size (2018-2029)
2 Immunofluorescence Assays Market by Type
2.1 Introduction
2.1.1 Antibodies
2.1.2 Kits and Reagents
2.1.3 Labeling Dyes
2.2 Global Immunofluorescence Assays Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immunofluorescence Assays Historic Market Size by Type (2018-2023)
2.2.2 Global Immunofluorescence Assays Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immunofluorescence Assays Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immunofluorescence Assays Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immunofluorescence Assays Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immunofluorescence Assays Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immunofluorescence Assays Revenue Breakdown by Type (2018-2029)
3 Immunofluorescence Assays Market Overview by Application
3.1 Introduction
3.1.1 Clinical Research
3.1.2 Laboratory Diagnostics
3.2 Global Immunofluorescence Assays Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immunofluorescence Assays Historic Market Size by Application (2018-2023)
3.2.2 Global Immunofluorescence Assays Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immunofluorescence Assays Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immunofluorescence Assays Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immunofluorescence Assays Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immunofluorescence Assays Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immunofluorescence Assays Revenue Breakdown by Application (2018-2029)
4 Immunofluorescence Assays Competition Analysis by Players
4.1 Global Immunofluorescence Assays Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunofluorescence Assays as of 2022)
4.3 Date of Key Players Enter into Immunofluorescence Assays Market
4.4 Global Top Players Immunofluorescence Assays Headquarters and Area Served
4.5 Key Players Immunofluorescence Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Immunofluorescence Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher
5.1.1 Thermo Fisher Profile
5.1.2 Thermo Fisher Main Business
5.1.3 Thermo Fisher Immunofluorescence Assays Products, Services and Solutions
5.1.4 Thermo Fisher Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Recent Developments
5.2 Inova Diagnostics
5.2.1 Inova Diagnostics Profile
5.2.2 Inova Diagnostics Main Business
5.2.3 Inova Diagnostics Immunofluorescence Assays Products, Services and Solutions
5.2.4 Inova Diagnostics Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.2.5 Inova Diagnostics Recent Developments
5.3 Bio-Rad
5.3.1 Bio-Rad Profile
5.3.2 Bio-Rad Main Business
5.3.3 Bio-Rad Immunofluorescence Assays Products, Services and Solutions
5.3.4 Bio-Rad Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.3.5 Abcam Recent Developments
5.4 Abcam
5.4.1 Abcam Profile
5.4.2 Abcam Main Business
5.4.3 Abcam Immunofluorescence Assays Products, Services and Solutions
5.4.4 Abcam Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.4.5 Abcam Recent Developments
5.5 PerkinELmer
5.5.1 PerkinELmer Profile
5.5.2 PerkinELmer Main Business
5.5.3 PerkinELmer Immunofluorescence Assays Products, Services and Solutions
5.5.4 PerkinELmer Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.5.5 PerkinELmer Recent Developments
5.6 Merck Millipore
5.6.1 Merck Millipore Profile
5.6.2 Merck Millipore Main Business
5.6.3 Merck Millipore Immunofluorescence Assays Products, Services and Solutions
5.6.4 Merck Millipore Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Millipore Recent Developments
5.7 Cell Signaling Technology
5.7.1 Cell Signaling Technology Profile
5.7.2 Cell Signaling Technology Main Business
5.7.3 Cell Signaling Technology Immunofluorescence Assays Products, Services and Solutions
5.7.4 Cell Signaling Technology Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.7.5 Cell Signaling Technology Recent Developments
5.8 MEDIPAN GMBH
5.8.1 MEDIPAN GMBH Profile
5.8.2 MEDIPAN GMBH Main Business
5.8.3 MEDIPAN GMBH Immunofluorescence Assays Products, Services and Solutions
5.8.4 MEDIPAN GMBH Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.8.5 MEDIPAN GMBH Recent Developments
5.9 Sino Biological
5.9.1 Sino Biological Profile
5.9.2 Sino Biological Main Business
5.9.3 Sino Biological Immunofluorescence Assays Products, Services and Solutions
5.9.4 Sino Biological Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.9.5 Sino Biological Recent Developments
5.10 Danaher
5.10.1 Danaher Profile
5.10.2 Danaher Main Business
5.10.3 Danaher Immunofluorescence Assays Products, Services and Solutions
5.10.4 Danaher Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.10.5 Danaher Recent Developments
5.11 Vector Laboratories
5.11.1 Vector Laboratories Profile
5.11.2 Vector Laboratories Main Business
5.11.3 Vector Laboratories Immunofluorescence Assays Products, Services and Solutions
5.11.4 Vector Laboratories Immunofluorescence Assays Revenue (US$ Million) & (2018-2023)
5.11.5 Vector Laboratories Recent Developments
6 North America
6.1 North America Immunofluorescence Assays Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immunofluorescence Assays Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immunofluorescence Assays Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immunofluorescence Assays Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immunofluorescence Assays Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immunofluorescence Assays Market Dynamics
11.1 Immunofluorescence Assays Industry Trends
11.2 Immunofluorescence Assays Market Drivers
11.3 Immunofluorescence Assays Market Challenges
11.4 Immunofluorescence Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’